Diana Maichin is a Senior Associate for GE Ventures, General Electric Company’s corporate venture arm, based in Menlo Park, California. In this role, she tracks the Incubation group's deal flow, performs industry and financial due diligence on targeted companies, and drives growth strategy for Incubation’s portfolio companies.
Diana focuses on healthcare investing, particularly employer health, and seeks targets with the opportunities to bend or break the cost curve for mid- to jumbo-sized employers.
Prior to GE Ventures, Diana interned at Kleiner Perkins Caufield & Byers, focusing on digital health opportunities. Earlier, Diana worked at Codexis, where she proposed an enzyme pricing strategy for a large pharma client and instituted financial planning tools for the pharmaceutical business unit. At Financial Technology Partners, a boutique investment bank in San Francisco, Diana covered healthcare IT companies, including the Accretive Health IPO.
Diana started her healthcare career at Genentech, where she held roles in supply chain, manufacturing, external quality, and finance. She worked on a risk assessment for the largest biotechnology manufacturing site in the world and identified opportunities to increase royalty income for a $2B global business.
Education, Personal, and Fellowship
Diana earned an MBA from Harvard Business School in 2013. She holds a BS in chemical engineering, summa cum laude, from Rensselaer Polytechnic Institute (RPI) and a graduate certificate in product creation and innovation from Stanford University. She is a black-diamond snowboarder and loves travelling to taste the coffee, wine, and cheese of the world with her life explorer, Julian.
Diana served her fellowship at GE Ventures as a member of Class 21, under the mentorship of Risa Stack (Class 2), General Manager of GE Ventures, Incubations.